Important information on minimizing the risk of aortic aneurysm and dissection and heart valve regurgitation/incompetence with the use of levofloxacin

05.10.2022 1185 views

Важлива інформація з мінімізації ризику аневризми та дисекції аорти та регургітації/недостатності серцевого клапана при застосуванні левофлоксацинуPDF · 568 КБ

Завантажити

Important information on minimizing the risk of aortic aneurysm and dissection and heart valve regurgitation/incompetence with the use of levofloxacin

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Important information on minimizing the risk of aortic aneurysm and dissection and heart valve regurgitation/incompetence with the use of levofloxacin

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration